Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Europe (Supplemental) | 2024

The biosurgical agent market in Europe will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides high-level market metrics for biosurgical agents in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2032.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe (Supplemental)
The European large-joint reconstructive implant market is poised for long-term growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants, as well as…
Report
Neurovascular Devices – Market Insights – Europe
The European neurovascular device market is poised to experience strong growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…